MECANISMOS EPIGENÉTICOS NO DESENVOLVIMENTO DO CÂNCER
Main Article Content
Abstract
Introduction: Epigenetics, a field of study dedicated to the mechanisms that regulate gene expression without modifying the DNA sequence, encompasses changes resulting from alterations in the DNA bases and the superstructure of their packaging. DNA, organized into repeating units called nucleosomes, forms a histone complex made up of H2A, H2B, H3 and H4. Modifications to these histone proteins can facilitate or hinder access to DNA by the replication and transcription machinery, impacting on gene expression patterns. These changes, although not permanent, can last for several generations and are susceptible to influences such as age, environment and specific disease states. Objective: To analyze the complexities of epigenetics, focusing on the mechanisms that regulate gene expression without modifying the DNA sequence. In addition, we sought to understand how changes in these mechanisms, especially those related to DNA methylation, histone modifications and genomic imprinting, are associated with the emergence of different types of cancer. Methodology: This is a literature review. Articles were obtained from the Scientific Electronic Library Online (SciELO), PubMed and Web of Science databases, using descriptors registered with Decs. Articles published between 2015 and 2023 in peer-reviewed journals were selected, with the languages considered being Portuguese and English. The analysis of the articles aimed to identify correlations between epigenetic mechanisms and cancer incidence, with an emphasis on persistent epigenetic changes over generations. Results: The results of this literature review indicate that alterations in DNA methylation at key sites in the genome are directly associated with the development of cancer. Recent literature highlights the potential of abnormal DNA methylation as a biomarker for cancer, highlighting the relevance of these epigenetic mechanisms in understanding neoplastic genesis. The analysis also revealed that factors such as histone modifications and genomic imprinting play a crucial role in this context. Final considerations: The importance of epigenetic mechanisms in the context of cancer has provided a comprehensive view of how these alterations contribute to the formation of neoplastic cells. Understanding these processes opens the door to the development of more sensitive diagnostic methods and more effective treatments. This study contributes to updating scientific knowledge by identifying recent relationships between epigenetic mechanisms and different types of cancer, offering valuable perspectives for future therapeutic approaches and early diagnosis.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
AL ABOUD, N. M.; TUPPER, C.; JIALAL, I. Genetics, Epigenetic Mechanism. Treasure Island (FL): StatPearls Publishing; August 14, 2023. Disponível em: https://pubmed.ncbi.nlm.nih.gov/30422591/. Acessado em: Nov. 2023.
ARRIETA, P. et al. DNMT3B modulates the expression of cancerrelated genes and downregulates the expression of the gene VAV3 via methylation. Am. J. Cancer. Res., v. 7, n. 1, p. 77-87, 2017. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5250682/. Acessado em: Nov. 2023.
BERDASCO, M.; ESTELLER, M. Clinical epigenetics: seizing opportunities for translation. Nat. Rev. Genet., v. 20, n. 2, p. 109-127, Fev. 2019. Disponível em: https://doi.org/10.1038/s41576-018-0074-2. Acessado em: Nov. 2023.
BHAT, M. A.; ANUPA, G.; GHOSH, D. Transgenerational epigenetic inheritance: Where do we stand today?. Journal of Reproductive Health and Medicine I, Fev. 2015. Disponível em: https://doi.org/10.1016/j.jrhm.2015.01.007. Acessado em: Nov. 2023.
BÖCK, J. et al. Single CpG hypermethylation, allele methylation errors, and decreased expression of multiple tumor supressor genes in normal body cells of mutation-negative early-onset and high-risk breast cancer patients. Int. J. Cancer., v. 15, n. 143, p. 1416-1425, Set. 2018. Disponível em: Disponível em: https://doi.org/10.1002/ijc.31526. Acessado em: Nov. 2023.
CHAKMA , K. et al. Epigenetic inactivation of IRX4 is cancer. Cancer Sci., v. 111, n. 12, p. 4594-4604, Out. 2020. Disponível em: https://doi.org/10.1111/cas.14644. Acessado em: Nov. 2023.
CHAN, S. The Importance of Epigenetic Phenomena in Regulating Activity of the Genetic Material. 2013. Disponível em: https://digitalcommons.uri.edu/srhonorsprog/348. Acessado em: Nov. 2023.
CHEN, J. et al. High-Resolution Bisulfite-Sequencing of Peripheral Blood DNA Methylation in Early-Onset and Familial Risk Breast Cancer Patients. Clin. Cancer. Res., v. 1, n. 25, p. 5301-5314, Set. 2019. Disponível em: https://doi.org/10.1158/1078-0432.CCR-18-2423. Acessado em: Nov. 2023.
CHOI, S. J. et al. Alteration of DNA Methylation in Gastric Cancer with Chemotherapy. J. Microbiol. Biotechnol., v. 28, n. 27, p. 1367-1378, Ago. 2017. Disponível em: https://doi.org/10.4014/jmb.1704.04035. Acessado em: Nov. 2023.
DEICHMANN, U. Epigenetics: The origins and evolution of a fashionable topic. Developmental Biology, v. 416, n. 1, p. 249–254, Ago. 2016. Disponível em: https://doi.org/10.1016/j.ydbio.2016.06.005. Acessado em: Nov. 2023.
DÍEZ-VILLANUEVA, A. et al. DNA methylation events in transcription factors and gene expression changes in colon cancer. Epigenomics., v. 12, n. 18, p. 1593-1610, Set. 2020. Disponível em: https://doi.org/10.2217/epi-2020-0029 Acessado em: Nov. 2023.
FEINBERG, A.; KOLDOBSKIY, M.; GÖNDÖR, A. Epigenetic modulators, modifiers and mediators in cancer aetiology and progression. Nat. Rev. Genet., v. 17, n. 5, p. 284-99, Maio 2016. Disponível em: https://doi.org/10.1038/nrg.2016.13. Acessado em: Nov. 2023.
HAN, Q. et al. Association between the methylation of the STAT1 and SOCS3 in peripheral blood and gastric cancer. J. Gastroenterol. Hepatol., v. 35, n. 8, p. 1347-1354, Ago. 2020. Disponível em: https://doi.org/10.1111/jgh.15021. Acessado em: Nov. 2023.
JONES, P. A.; ISSA, J. P.; BAYLIN, S. Targeting the cancer epigenome for therapy. Nat. Rev. Genet., v. 15, n. 17, p. 630-641, Set. 2016. Disponível em: https://doi.org/10.1038/nrg.2016.93. Acessado em: Nov. 2023.
KLEMM, S. L.; SHIPONY, Z.; GREENLEAF, W. J. Chromatin accessibility and the regulatory epigenome. Nat. Rev. Genet. v. 20, n. 4, p. 207-220, Abr. 2019. Disponível em: https://doi.org/10.1038/s41576-018-0089-8. Acessado em: Nov. 2023.
LEE, J. et al. Epigenetic reprogramming of epithelialmesenchymal transition promotes ferroptosis of head and neck cancer. Redox Biol., v. 37, p. 101697, Out. 2020. Disponível em: https://doi.org/10.1016/j.redox.2020.101697. Acessado em: Nov. 2023.
LIU, C. et al. Status of Gene Methylation and Polymorphism in Different Courses of Ulcerative Colitis and Their Comparison with Sporadic Colorectal Cancer. Inflamm. Bowel. Dis., v. 15, n. 27, p. 522-529, Mar. 2021. Disponível em: https://doi.org/10.1093/ibd/izaa203. Acessado em: Nov. 2023.
LIU, J. et al. Transplacental arsenic exposure produced 5-methylcytosine methylation changes and aberrant microRNA expressions in livers of male fetal mice. Toxicology., v. 15, p. 435:152409, Abr. 2020. Disponível em: https://doi.org/10.1016/j.tox.2020.152409. Acessado em: Nov. 2023.
MOOSAVI, A.; MOTEVALIZADEH, A. A. Role of Epigenetics in Biology and Human Diseases. Iran. Biomed. J., v. 20, n. 5, p. 246-58, Nov. 2016. Disponível em: https://doi.org/10.22045/ibj.2016.01. Acessado em: Nov. 2023.
OLIVEIRA, M. M. et al. Estimated number of people diagnosed with cancer in Brazil: data from the National Health Survey, 2013. Rev. Bras. Epidemiol. v. 18, n. 2, p. 146–57, Dez. 2015. Disponível em: https://doi.org/10.1590/1980-5497201500060013. Acessado em: Nov. 2023.
PERRI, F. et al. Epigenetic control of gene expression: Potential implications forcancer treatment. Critical Reviews in Oncology/Hematology, v. 111, p. 166-172, Mar. 2017. Disponível em: https://doi.org/10.1016/j.critrevonc.2017.01.020. Acessado em: Nov. 2023.
PISANIC II, et al. Defining, distinguishing and detecting the contribution of heterogeneous methylation to cancer heterogeneity. Semin Cell Dev Biol, Abr. 2017. Disponível em: http://dx.doi.org/10.1016/j.semcdb.2016.08.030. Acessado em: Nov. 2023.
WANG, L. et al. Loss of Tumor Suppressor Gene Function in Human Cancer: na Overview. Cell Physiol. Biochem., v. 51, n. 6, p. 2647-2693, Dez. 2018. Disponível em: https://doi.org/10.1159/000495956. Acessado em: Nov. 2023.